Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety

所属期刊栏目：13

资助基金：We thank the patients,their families,the investigators,and nurses,who participated in this trial.This research was funded by Bristol-Myers Squibb.Third-party writing assistance was funded by Bristol-Myers Squibb and provided by Manette Williams,PhD

在线出版日期：2019-07-04（万方平台首次上网日期，不代表论文的发表时间）

页数：共10页

页码：344-353